Xanax (alprazolam) has the highest abuse potential of all commonly prescribed benzodiazepines. Its rapid onset (15-30 minutes) and short half-life (6-12 hours) create a reinforcing cycle: quick relief followed by rebound anxiety between doses, which drives dose escalation. Physical dependence can de

Benzodiazepine

How do you stop taking Xanax safely?

Q: What are Xanax withdrawal symptoms?

Xanax withdrawal symptoms include rebound anxiety (often worse than the original anxiety), insomnia, irritability, muscle tension, tremors, sweating, and difficulty concentrating. In severe cases — particularly after high doses or prolonged use — withdrawal can cause seizures, which is why medical s

Direct Answer

Stopping Xanax requires a slow, medically supervised taper — never stop abruptly. A typical taper reduces the dose by 10-25% every 1-2 weeks, and the entire process can take weeks to months depending on your dose and duration of use. Many clinicians switch patients to a longer-acting benzodiazepine like diazepam (Valium) first, because its longer half-life produces smoother blood levels and an easier taper. Warning symptoms during tapering include increased anxiety, insomnia, tremor, and in severe cases, seizures. This is one of the few medications where unsupervised withdrawal can be medically dangerous.

Based on published clinical trial data and FDA prescribing information. This is not medical advice — always consult your healthcare provider.

Supporting Evidence

Stopping Safely

CRITICAL — Never Stop AbruptlyTimeframe: 3–24 months depending on dose and duration of use

Abrupt alprazolam discontinuation can cause life-threatening seizures. Benzodiazepine withdrawal is one of the two withdrawal syndromes (with alcohol) that can be directly fatal. Tapering must be slow and medically supervised.

Warning symptoms:

Seizures — call 911 immediately
Tremors or uncontrollable shaking
Extreme anxiety or panic disproportionate to your normal level

Side Effects

Sedation / drowsiness41%

Memory impairment30%

Coordination problems / ataxia20%

Rebound anxiety when stopping>50%

Tolerance (reduced efficacy over time)40%+

Serious (rare)

Physical dependence and addiction (40–60% of patients using >6 weeks)
Withdrawal seizures if stopped abruptly — can be life-threatening
Respiratory depression when combined with opioids or alcohol

Drug Interactions

MAJOR

Opioids (oxycodone, hydrocodone, tramadol)— Respiratory depression — risk of death. FDA black box warning. Combined use accounts for thousands of overdose deaths annually.

MAJOR

Other benzodiazepines / CNS depressants— Profound additive sedation and respiratory depression.

MOD

Fluoxetine, fluvoxamine (SSRIs)— CYP3A4 inhibition increases alprazolam levels by 50–100%, worsening sedation and dependence risk.

MOD

Itraconazole, ketoconazole (antifungals)— Strong CYP3A4 inhibitors significantly raise alprazolam blood levels.

Funding transparency: Virtually all pivotal Xanax trials were funded by Upjohn (now Pfizer). The manufacturer shaped dosing guidelines, minimized addiction data, and omitted long-term dependence findings from early publica… See full funding details

Read the complete Xanax® guide

Side effect rates, clinical trial data, funding transparency, drug interactions, tapering protocols, and lifestyle alternatives — all in one place.

View Xanax®